Cargando…
Jia-Wei-Yu-Ping-Feng-San Attenuates Group 2 Innate Lymphoid Cell-Mediated Airway Inflammation in Allergic Asthma
The incidence of asthma has increased in recent decades. Although corticosteroids and bronchodilators are used in clinical practice, the control of asthma remains a challenge. Allergic asthma is characterized airway inflammation mediated by type 2 immune response. Group 2 innate lymphoid cells (ILC2...
Autores principales: | Xue, Lingna, Li, Cui, Ge, Guangbo, Zhang, Shaoyan, Tian, Liming, Wang, Yu, Zhang, Huiyong, Ma, Zifeng, Lu, Zhenhui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8299004/ https://www.ncbi.nlm.nih.gov/pubmed/34305612 http://dx.doi.org/10.3389/fphar.2021.703724 |
Ejemplares similares
-
Screening Active Components from Yu-Ping-Feng-San for Regulating Initiative Key Factors in Allergic Sensitization
por: Shen, Dandan, et al.
Publicado: (2014) -
Yu ping feng san for pediatric allergic rhinitis: A systematic review and meta-analysis of randomized controlled trials
por: Liao, Yong, et al.
Publicado: (2021) -
Yu ping feng san for pediatric allergic rhinitis: A systematic review and meta-analysis of randomized controlled trials: Erratum
Publicado: (2021) -
Mechanisms and molecular targets of the Yu-Ping-Feng powder for allergic rhinitis, based on network pharmacology
por: Yang, Shasha, et al.
Publicado: (2021) -
Mechanism of YuPingFeng in the Treatment of COPD Based on Network Pharmacology
por: Yin, Yunhong, et al.
Publicado: (2020)